Therapy of gastric lymphoma of MALT type, including antibiotics
This chapter addresses the systemic therapy of marginal B cell lymphoma, a category which comprises MALT-type lymphomas and monocytoid B cell lymphomas [20. 1]. These two different subtypes are approximately equal in frequency,1 but this chapter restricts its scope to lymphomas of the stomach.
KeywordsLymphoma Oncol Gastritis
Unable to display preview. Download preview PDF.
- 1.Fisher RI, Dahlberg S, Nathwani BN, Banks PIVI, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood 1995; 85:1075–82.PubMedGoogle Scholar
- 13.Fisher RI. CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphoma. Important Adv Oncol 1990; 217–25.Google Scholar
- del Valle F, Hiddemann W, Willich N et al. (for the German Multicenter Study Group on GI-NHL). Clinical presentation of 371 primary gastrointestinal lymphoma: Results of a prospective multicenter study. Blood 1997; 90 (Suppl 1), 338a (abstract 1507).Google Scholar
- Koch P, del Valle F, Hiddemann W et al. (for the German Multicenter Study Group on GI-NHL). Primary gastrointestinal (GI) lymphoma in 371 patients: Data from a prospective multicentre study. Blood 1997; 90 (Suppl 1): 586a (abstract 2608).Google Scholar